Hemodynamics-guided therapy for hypertensive disorders of pregnancy: a systematic review
Open Access
- 14 January 2026
- journal article
- review article
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 313 (1) , 43
Abstract
Objective: Despite on-going research into the underlying pathology of hypertensive disorders in pregnancy, maternal mortality is hardly decreasing. Current antihypertensive therapy is aimed at controlling symptoms and preventing severe courses of pregnancy. Traditional management focuses on blood pressure (BP) control, but does not consider individual hemodynamic variations. Hemodynamically guided therapy offers a personalized approach that can improve BP control and outcomes by treating the underlying pathophysiology. The aim of this review is to provide an overview of hemodynamically guided antihypertensive therapy in hypertensive disorders of pregnancy and to present the results of recent intervention trials in this area. Methods: Literature searches were conducted in the electronic databases PubMed, CENTRAL, and Google scholar from inception to May 2024 for studies that used maternal hemodynamic parameters like cardiac output (CO) or TPVR (total peripheral vascular resistance) to guide antihypertensive therapy in pregnant women with hypertensive disorders or at elevated risk for developing preeclampsia. The review included intervention studies. Results: A total of five studies met the inclusion criteria. All studies showed improved BP control when the antihypertensive medication administered was matched to hemodynamic characteristics of the women being treated. Using a personalized approach, pregnancy complications were significantly reduced in patients with both hypo- or hyperdynamic circulation, even in patients with a history of preeclampsia. Conclusion: The study shows that hemodynamically triggered antihypertensive therapy can improve outcomes for both mother and child in cases of hypertensive pregnancy disorders. However, further placebo-controlled studies are necessary before a final assessment of this therapy can be made.Keywords
Funding Information
- German Federal Ministry of Education and Research (01GR2305A)
- Universitätsklinikum Jena
This publication has 59 references indexed in Scilit:
- Outcomes of Pregnancies at Risk for Hypertensive Complications Managed Using Impedance CardiographyAmerican Journal of Perinatology, 2009
- Antihypertensive Therapy and Central Hemodynamics in Women With Hypertensive Disorders in PregnancyObstetrics & Gynecology, 2009
- Hemodynamically-Directed Atenolol Therapy is Associated with a Blunted Rise in Maternal sFLT–1 Levels During PregnancyHypertension in Pregnancy, 2009
- Early and Late PreeclampsiaHypertension, 2008
- Maternal and fetal hemodynamic effects induced by nitric oxide donors and plasma volume expansion in pregnancies with gestational hypertension complicated by intrauterine growth restriction with absent end‐diastolic flow in the umbilical arteryUltrasound in Obstetrics & Gynecology, 2007
- Value of Noninvasive Hemodynamics to Achieve Blood Pressure Control in Hypertensive SubjectsHypertension, 2006
- Resistant HypertensionHypertension, 2002
- Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension*1Obstetrics & Gynecology, 1999
- Hemodynamic effects of oral nifedipine in preeclamptic hypertensive emergenciesAmerican Journal of Obstetrics and Gynecology, 1996
- The effect of maternal hemodynamics on fetal growth in hypertensive pregnanciesAmerican Journal of Obstetrics and Gynecology, 1991